What is Adaptive Biotechnologies's PP&E (net)?

Adaptive Biotechnologies (ADPT) reported PP&E (net) of $30.77M in Q1 2026.

How has Adaptive Biotechnologies's PP&E (net) changed year-over-year?

Adaptive Biotechnologies's PP&E (net) decreased by 30.7% year-over-year, from $44.43M to $30.77M.

What is the long-term trend for Adaptive Biotechnologies's PP&E (net)?

Over 5 years (2020 to 2025), Adaptive Biotechnologies's PP&E (net) has grown at a -3.0% compound annual growth rate (CAGR), from $39.69M to $34.11M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Adaptive Biotechnologies ADPT PP&E (Net)

PP&E (Net) at other companies

Guardant HealthGH

$150.04M+16.0%

Natera, Inc.NTRA

$269.38M+49.3%

Monte Rosa Therapeutics, Inc.GLUE

$28.41M-3.2%

GeneDx HoldingsWGS

$50.13M+37.8%

VeracyteVCYT

$22.65M+0.5%

Nurix Therapeutics, Inc.NRIX

$21.7M+17.6%

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's PP&E (net)?: Adaptive Biotechnologies (ADPT) reported PP&E (net) of $30.77M in Q1 2026.
How has Adaptive Biotechnologies's PP&E (net) changed year-over-year?: Adaptive Biotechnologies's PP&E (net) decreased by 30.7% year-over-year, from $44.43M to $30.77M.
What is the long-term trend for Adaptive Biotechnologies's PP&E (net)?: Over 5 years (2020 to 2025), Adaptive Biotechnologies's PP&E (net) has grown at a -3.0% compound annual growth rate (CAGR), from $39.69M to $34.11M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.